HbA1c: the glucose management indicator, time in range, and standardization of continuous glucose monitoring reports in clinical practice [review] Review uri icon
  • Continuous glucose monitoring (CGM) use is growing rapidly among people with diabetes and beginning to be standard of care for managing glucose levels in insulin therapy. With this increased use, there is a need to standardize CGM data. CGM standardization has been set forth by expert panels. The Glucose Management Indicator is a concept using the CGM-derived mean glucose to provide a value that can be understood similarly to hemoglobin A1c. The times an individual spends in various glucose ranges is emerging as an important set of metrics. Metrics derived from patient CGM data are changing the way diabetes is managed.

  • Link to Article
    publication date
  • 2020
  • Research
  • Biomarkers
  • Blood
  • Diabetes
  • Drugs and Drug Therapy
  • Monitoring, Physiologic
  • Physician's Practice Patterns
  • Additional Document Info
  • 49
  • issue
  • 1